A novel PDT: 5-aminolevulinic acid combined 450 nm blue laser photodynamic therapy significantly promotes cell death of HR-HPV infected cells
Source abstract
Abstract
Human papillomavirus (HPV) infection and related diseases are clinical challenges. The efficacy of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) using red laser (630 ± 5 nm) is remarkable and safe. In this study, we aim to investigate the efficacy of ALA-450 nm PDT comparing with ALA-635 nm PDT. We detected cell proliferation and cell apoptosis through MTT assay and flow cytometry assay respectively. Flow cytometry assay determined the intracellular reactive oxygen species (ROS) generation. Western blotting analysis investigated the protein expression. In vivo, immunohistochemical staining assay and TUNEL assay were performer to detect cell apoptosis. ALA-450 nm PDT inhibited the proliferation of End1 and HeLa cells, promoted cell apoptosis more effectively than ALA-635 nm PDT, and induced cell death probably through increasing the intracellular ROS generation and caspase-dependent apoptosis pathway. In vivo, ALA-450 nm PDT significantly inhibited tumour growth and activated cell apoptosis. The ALA-450 nm PDT had an advantage over ALA-635 nm PDT on inhibiting the proliferation of End1 and HeLa cells and inducing cell apoptosis. The ALA-450 nm PDT might be a promising therapeutic strategy for eradicating the HR-HPV infected cells and promoting the integration of diagnosis and treatment of HR-HPV related diseases.HighlightsWe combined 5-aminolevulinic acid with 450 nm blue laser using as a novel type of photodynamic therapy.The ALA-450 nm PDT had an advantage over ALA-635 nm PDT on inhibition of the proliferation of End1 and HeLa cells and inducing cell apoptosis in vitro and in vivo.The ALA-450 nm PDT may provide a novel alternative therapeutic option in patients with persistent HPV infection and promote the integration of diagnosis and treatment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Photodynamic Therapy Research Studies · Cervical Cancer and HPV Research · Oral Health Pathology and Treatment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Urology, The First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi, China
Department of Obstetrics and Gynecology, Shaanxi Provincial People’s Hospital, Shaanxi, China
Funding
the National Natural Science Foundation of China in 2021 · Key Research and Development Program of Shaanxi
References (51)
Show source-provided references
1. 10.3390/v1311223410.3390/v13112234 ↗
2. 10.1016/j.pdpdt.2015.07.00410.1016/j.pdpdt.2015.07.004 ↗
3. 10.1016/S0140-6736(13)60022-710.1016/S0140-6736(13)60022-7 ↗
4. 10.1093/jnci/93.4.28410.1093/jnci/93.4.284 ↗
5. 10.1080/01443615.2019.163403010.1080/01443615.2019.1634030 ↗
6. 10.1111/j.1396-0296.2004.04047.x10.1111/j.1396-0296.2004.04047.x ↗
7. 10.1016/j.ogc.2013.03.00310.1016/j.ogc.2013.03.003 ↗
8. Lacey CJ. · J Clin Virol · 2005 · 32 · s8210.1016/j.jcv.2004.10.020 ↗
9. 10.1046/j.1525-1500.1999.99036.x10.1046/j.1525-1500.1999.99036.x ↗
10. Fukuhara H · Int J Clin Oncol · 2021 · 26 · 1810.1007/s10147-020-01704-y ↗
11. Giomi B · G Ital Dermatol Venereol · 2012 · 147 · 467
12. Wang HW · Photochem Photobiol · 2012 · 88 · 56510.1111/j.1751-1097.2011.01060.x ↗
13. Nkune NW · IJMS · 2021 · 22 · 1261810.3390/ijms222312618 ↗
14. Alexiades-Armenakas M. · Clin Dermatol · 2006 · 24 · 1610.1016/j.clindermatol.2005.10.027 ↗
15. 10.1016/j.pdpdt.2021.10227110.1016/j.pdpdt.2021.102271 ↗
16. Radakovic S · J Dtsch Dermatol Ges · 2020 · 18 · 49210.1111/ddg.14084_g ↗
17. 10.1016/j.pdpdt.2020.10181910.1016/j.pdpdt.2020.101819 ↗
18. Xie F · J Cutan Med Surg · 2019 · 23 · 37010.1177/1203475419838548 ↗
19. 10.1016/j.pdpdt.2018.08.00610.1016/j.pdpdt.2018.08.006 ↗
20. Fichorova RN · Biol Reprod · 1997 · 57 · 84710.1095/biolreprod57.4.847 ↗
21. 10.1039/c9pp00211a10.1039/c9pp00211a ↗
22. 10.1111/phpp.1275410.1111/phpp.12754 ↗
23. 10.1002/cncr.3058810.1002/cncr.30588 ↗
24. Hu Z · Photodiagnosis Photodyn Ther · 2018 · 23 · 36210.1016/j.pdpdt.2018.07.014 ↗
25. 10.1016/j.pdpdt.2021.10253010.1016/j.pdpdt.2021.102530 ↗
26. Shan X · Indian J Dermatol Venereol Leprol · 2016 · 82 · 6510.4103/0378-6323.171649 ↗
27. 10.1080/09546634.2019.156975210.1080/09546634.2019.1569752 ↗
28. 10.1016/j.tice.2022.10185610.1016/j.tice.2022.101856 ↗
29. 10.1016/j.jphotobiol.2019.03.01210.1016/j.jphotobiol.2019.03.012 ↗
30. 10.1111/phpp.1266310.1111/phpp.12663 ↗
31. Ahn TG · Gynecol Oncol Case Rep · 2012 · 2 · 5410.1016/j.gynor.2012.01.004 ↗
32. Choi MC · Photodiagnosis Photodyn Ther · 2014 · 11 · 42010.1016/j.pdpdt.2014.06.001 ↗
33. 10.1007/s11060-019-03103-410.1007/s11060-019-03103-4 ↗
34. Cramer SW · Front. Surg · 2020 · 6 · 8110.3389/fsurg.2019.00081 ↗
35. 10.1002/lsm.2293310.1002/lsm.22933 ↗
36. 10.1016/j.clineuro.2020.10643010.1016/j.clineuro.2020.106430 ↗
37. 10.1016/j.jphotobiol.2019.11154410.1016/j.jphotobiol.2019.111544 ↗
38. Naidoo C · Molecules (Basel, Switzerland · 2019 · 24 · 315310.3390/molecules24173153 ↗
39. 10.1111/jocd.1223610.1111/jocd.12236 ↗
40. Jin X · Photodiagnosis Photodyn Ther · 2019 · 28 · 14610.1016/j.pdpdt.2019.08.005 ↗
41. 10.3390/cancers1202033510.3390/cancers12020335 ↗
42. Wu H · Dig Endosc · 2019 · 31 · 50810.1111/den.13353 ↗
43. 10.1016/j.pdpdt.2018.08.01410.1016/j.pdpdt.2018.08.014 ↗
44. Lee SH · Cell Death Dis · 2021 · 12 · 99710.1038/s41419-021-04301-7 ↗
45. 10.1016/j.virol.2012.12.00410.1016/j.virol.2012.12.004 ↗
46. 10.1016/j.bbrc.2013.02.13010.1016/j.bbrc.2013.02.130 ↗
47. 10.1128/JVI.00974-1010.1128/JVI.00974-10 ↗
48. Menges CW · Cancer Res · 2006 · 66 · 555510.1158/0008-5472.CAN-06-0499 ↗
49. 10.1016/j.tranon.2022.10138810.1016/j.tranon.2022.101388 ↗
50. 10.5005/jp-journals-10024-193310.5005/jp-journals-10024-1933 ↗
51. Hess M · Laryngorhinootologie · 2020 · 99 · 60710.1055/a-1071-0410 ↗